X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (857) 857
Patent (539) 539
Publication (112) 112
Paper (89) 89
Conference Proceeding (26) 26
Book Chapter (5) 5
Book / eBook (3) 3
Streaming Audio (2) 2
Book Review (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Technical Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (289) 289
human necessities (281) 281
hygiene (270) 270
medical or veterinary science (270) 270
surgery (228) 228
diagnosis (225) 225
female (218) 218
identification (216) 216
prostheses (208) 208
bandages, dressings or absorbent pads (207) 207
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (207) 207
filters implantable into blood vessels (207) 207
first-aid kits (207) 207
fomentation (207) 207
orthopaedic, nursing or contraceptive devices (207) 207
treatment or protection of eyes or ears (207) 207
medical and health sciences (189) 189
medicin och hälsovetenskap (189) 189
male (184) 184
adult (146) 146
middle aged (146) 146
clinical medicine (120) 120
klinisk medicin (117) 117
physics (116) 116
index medicus (105) 105
performing operations (99) 99
transporting (99) 99
aged (96) 96
experiment (96) 96
physics - high energy physics - experiment (93) 93
particle physics (90) 90
electricity (84) 84
paper (80) 80
high energy physics - experiment (79) 79
textiles (77) 77
sweden (76) 76
animals (64) 64
psychiatry (64) 64
conveying (63) 63
handling thin or filamentary material (63) 63
packing (63) 63
storing (63) 63
adolescent (58) 58
electric communication technique (57) 57
reumatologi och inflammation (54) 54
rheumatology and autoimmunity (54) 54
handling thin or filamentary material, e.g. sheets, webs,cables (52) 52
looms (52) 52
methods of weaving (52) 52
weaving (52) 52
woven fabrics (52) 52
medicin (51) 51
general tagging of cross-sectional technologies spanning over several sections of the ipc (47) 47
general tagging of new technological developments (47) 47
hep (47) 47
technical subjects covered by former uspc (47) 47
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (47) 47
psykiatri (46) 46
risk factors (45) 45
rheumatology (43) 43
high energy physics (42) 42
medicine (41) 41
experimental results (40) 40
mice (39) 39
transmission of digital information, e.g. telegraphiccommunication (39) 39
health sciences (38) 38
sweden - epidemiology (37) 37
cern lhc coll (36) 36
mechanical engineering (36) 36
particle physics - experiment (36) 36
cancer and oncology (34) 34
cancer och onkologi (34) 34
chemistry (34) 34
p p: colliding beams (33) 33
p p: scattering (33) 33
peptides (33) 33
dentistry (32) 32
radioimmunotherapy (32) 32
organic chemistry (31) 31
young adult (31) 31
blasting (30) 30
heating (30) 30
lighting (30) 30
metallurgy (30) 30
technical subjects covered by former us classification (30) 30
weapons (30) 30
hälsovetenskaper (29) 29
treatment outcome (29) 29
follow-up studies (28) 28
radiology, nuclear medicine & medical imaging (28) 28
aged, 80 and over (27) 27
analysis (27) 27
braiding (27) 27
knitting (27) 27
lace-making (27) 27
non-woven fabrics (27) 27
preparations for medical, dental, or toilet purposes (27) 27
research (27) 27
trimmings (27) 27
apparatus or methods for oral or dental hygiene (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1211) 1211
French (153) 153
German (134) 134
Swedish (94) 94
Spanish (31) 31
Norwegian (18) 18
Portuguese (18) 18
Finnish (17) 17
Danish (15) 15
Chinese (11) 11
Czech (10) 10
Icelandic (8) 8
Hungarian (7) 7
Italian (5) 5
Korean (5) 5
Polish (4) 4
Turkish (4) 4
Dutch (2) 2
Russian (2) 2
Croatian (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2007, Volume 66, Issue 10, pp. 1339 - 1344
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2015, Volume 74, Issue 5, pp. 890 - 896
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181704
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1212 - 1217
Objective To estimate the risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) both with and without exposure to biological therapy and to... 
SWEDEN | REGISTER | Rheumatoid Arthritis | SERIOUS INFECTION | Anti-TNF | MONOCLONAL-ANTIBODY | NECROSIS-FACTOR ANTAGONISTS | RHEUMATOLOGY | FACTOR THERAPY | Tuberculosis | Treatment | DISEASES | BRITISH-SOCIETY | AGENTS | INFLIXIMAB | Tuberculosis - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Risk Factors | Arthritis, Rheumatoid - epidemiology | Proportional Hazards Models | Immunoglobulin G - therapeutic use | Antibodies, Monoclonal - therapeutic use | Male | Sweden - epidemiology | Case-Control Studies | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Adult | Female | Aged | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Cohort Studies | Complications and side effects | Care and treatment | Usage | Biological products | Rheumatoid arthritis | Health aspects | Risk factors | Drugs | Disease | Laboratories | Bias | Rheumatology | Personal identification numbers | Estimates | Studies | Education | Immunotherapy | Quality | Rheumatism | Population | TNF inhibitors | Tumor necrosis factor-TNF | Chronic obstructive pulmonary disease | Basic Medicine | Immunologi inom det medicinska området | Medical and Health Sciences | Medicin och hälsovetenskap | Immunology in the medical area | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 06/2014, Volume 16, Issue 3, pp. R127 - R127
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 105 - 111
BackgroundSafety data on cancer risks following tumour necrosis factor α inhibitors (TNFi) in patients with spondyloarthritis (SpA) (here defined as ankylosing... 
RHEUMATOID-ARTHRITIS | FACTOR THERAPY | TUMOR-NECROSIS-FACTOR | COLORECTAL-CANCER | CLINICAL-TRIALS | BIOLOGICS REGISTER | MALIGNANCIES | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | SERIOUS INFECTIONS | Melanoma - epidemiology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Infliximab - therapeutic use | Incidence | Arthritis, Psoriatic - drug therapy | Adult | Female | Registries | Certolizumab Pegol - therapeutic use | Antirheumatic Agents - therapeutic use | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Lymphoma - epidemiology | Risk Assessment | Spondylitis, Ankylosing - drug therapy | Sweden - epidemiology | Prostatic Neoplasms - epidemiology | Adalimumab - therapeutic use | Lung Neoplasms - epidemiology | Denmark - epidemiology | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Cohort Studies | Etanercept - therapeutic use | Complications and side effects | Care and treatment | Tumor necrosis factor | Spondyloarthropathies | Dosage and administration | Risk factors | Cancer | Rheumatology and Autoimmunity | Ankylosing Spondylitis | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | Anti-TNF | Klinisk medicin | Outcomes research | Psoriatic Arthritis | Spondyloarthritis
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 970 - 978
Objective To assess the effect of comedication with conventional synthetic disease modifying antirheumatic drugs (csDMARDs) on retention to tumour necrosis... 
RHEUMATOID-ARTHRITIS | EFFICACY | Anti-TNF | METHOTREXATE | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | Spondyloarthritis | SOCIETY CLASSIFICATION CRITERIA | Ankylosing Spondylitis | DMARDs (synthetic) | IMMUNOGENICITY | TREATMENT RESPONSE | NECROSIS FACTOR THERAPY | INFLIXIMAB | CONTINUATION | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Humans | Middle Aged | Spondylitis, Ankylosing - drug therapy | Proportional Hazards Models | Immunoglobulin G - therapeutic use | Antibodies, Monoclonal - therapeutic use | Male | Spondylarthritis - drug therapy | Treatment Outcome | Methotrexate - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Survival Analysis | Adult | Female | Adalimumab | Drug Therapy, Combination | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Care and treatment | Antirheumatic agents | Tumor necrosis factor inhibitors | Spondyloarthropathies | Dosage and administration | Research | Ankylosing spondylitis | Risk factors | Studies | Inflammatory bowel disease | Immunoglobulins | Psoriasis | Disease | Socioeconomic factors | TNF inhibitors | Tumor necrosis factor-TNF | Arthritis | Patients | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | Klinisk medicin
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2010, Volume 69, Issue 6, pp. 1072 - 1076
Journal Article